Dithiolethiones are an important class of cancer chemopreventive agents. More than 50 new dithiolethione analogs were synthesized for structure-activity studies. Using selected dithiolethiones, studies were designed to measure protection against the hepatotoxicity of aflatoxin B, (AFB,) and relate it to the protection against carcinogenicity. Young male F344 rats were pretreated with 0.1 or 0.3 mmol dithiolethiones/kg body wt and challenged with toxic doses of AFBi (50 ^/g/100 g rat/day) on 2 successive days. One day later, the protection from hepatotoxicity was assessed by measuring serum hepatic enzymes, hepatic necrosis, and degree of bile duct cell proliferation. The ability of these dithiolethiones to prevent AFB! -induced tumorigenicity was assessed by quantifying the hepatic burden of putative preneoplastic lesions [placental glutathione S-transferase (GST-P)-positive foci]. Significant correlations (p < 0.01) were observed between these toxicological indices and GST-P focal burden (alanine aminotransferase, r = 0.943; sorbitol dehydrogenase, r = 0.897; histological index, r = 0.893; bile duct cell proliferation, r = 0.933). These results imply that inhibition of hepatotoxicity affords protection against hepatocarcinogenicity. The extent of protection from acute hepatotoxicity offers a simple, short-term biological endpoint to screen dithiolethiones and related compounds for their chemopreventive properties.
. Fundam. Appl. Toxicol. 32, [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] Dithiolethiones are an important class of cancer chemopreventive agents. More than 50 new dithiolethione analogs were synthesized for structure-activity studies. Using selected dithiolethiones, studies were designed to measure protection against the hepatotoxicity of aflatoxin B, (AFB,) and relate it to the protection against carcinogenicity. Young male F344 rats were pretreated with 0.1 or 0.3 mmol dithiolethiones/kg body wt and challenged with toxic doses of AFBi (50 ^/g/100 g rat/day) on 2 successive days. One day later, the protection from hepatotoxicity was assessed by measuring serum hepatic enzymes, hepatic necrosis, and degree of bile duct cell proliferation. The ability of these dithiolethiones to prevent AFB! -induced tumorigenicity was assessed by quantifying the hepatic burden of putative preneoplastic lesions [placental glutathione S-transferase (GST-P)-positive foci]. Significant correlations (p < 0.01) were observed between these toxicological indices and GST-P focal burden (alanine aminotransferase, r = 0.943; sorbitol dehydrogenase, r = 0.897; histological index, r = 0.893; bile duct cell proliferation, r = 0.933). These results imply that inhibition of hepatotoxicity affords protection against hepatocarcinogenicity. The extent of protection from acute hepatotoxicity offers a simple, short-term biological endpoint to screen dithiolethiones and related compounds for their chemopreventive properties. O 1996 Society of Toxicology Dithiolethiones hold great promise as cancer chemoprevention drugs. For example, 4-methyl-5-pyrazinyl-3//-l,2-dithiole-3-thione (OLT) 3 has been shown to be an ef-1 Preliminary accounts of this work were presented at the 1996 Annual Meeting of the American Association for Cancer Research, Washington, DC.
1 To whom requests for reprints should be addressed at Department of Pharmacology and Toxicology, Dartmouth Medical School, 7650 Remsen, Hanover, NH 03755. 3 Abbreviations used: OLT, 4-methyl-5-pvrazinyl-3//-l,2-dithiole-3-thione (oltipraz); AFB,, aflatoxin B,; ADT, 5-<4-methoxyphenyl)-3//-I,2-dithiole-3-thione; D3T, 3/Y-l,2-dithiole-3-thione; 5mD3T, 5-methyl-3//-1,2-dithiole-3-thione; D2T, 1,3-dithiole-2-thione; SALT, serum alanine amifective chemopreventive agent in many different rodent models of experimental carcinogenesis in target organs such as the small intestine, pancreas, lung, forestomach, colon, urinary bladder, trachea, liver, mammary gland, and skin (see Kensler and Helzlsouer, 1995, for references) . OLT has undergone phase I clinical trials to determine its pharmacokinetics and dose-limiting side effects during chronic administration to humans (Benson, 1993) . Phase II clinical trials are underway in Qidong, Jiangsu Province, People's Republic of China. This population is exposed to aflatoxin B, (AFB,) in their food supply and the trial is evaluating the effectiveness of OLT in modulating AFB i metabolism and disposition in vivo.
In humans several dithiolethiones are known to possess pharmaceutical properties other than cancer chemoprevention. For example, OLT has been used as an orally effective drug for the treatment of schistosomiasis. Single doses of OLT have achieved cure rates greater than 90% (Archer, 1985) . OLT is also an irreversible inhibitor of HIV reverse transcriptase and is currently in a clinical trial in AIDS patients (Prochaska et ai, 1995) . 5-(4-MethoxyphenyI)-3tf-1,2-dithiole-3-thione (ADT) is used currently as a choleretic drug and to stimulate salivary secretion (Hausler and Ritschard, 1979) . Thus, general tolerance of dithiolethiones and their acceptance in humans have been broadly examined.
While studying the antischistosomal properties of OLT, Bueding and associates (1982) noted that exposure of mice infected with Schistosoma mansoni to OLT increased levels of glutathione in host tissues while reducing glutathione stores of the parasite. These observations were expanded to show that OLT and other dithiolethiones were potent inducers of enzymes involved in the maintenance of the reduced glutathione pools as well as enzymes involved in electrophile detoxication, such as NAD(P)H:quinone reductase. epoxide hydrolase, UDP-glucuronosyl transferase, and gluta-thione S-transferase (Ansher et al, 1986) . The elevation of electrophile detoxication (phase 2) enzymes has been recognized as a characteristic action of many chemopreventive agents (Prochaska et al, 1985) . In contrast to marked induction of phase 2 enzymes, cytochrome P450 levels and other phase 1 enzyme activities were only slightly elevated by OLT (Kensler et al, 1985) . The initial confirmation of the predicted cancer chemopreventive activity of OLT came from demonstration that OLT afforded protection against the development of forestomach and/or pulmonary cancers induced by benzo[a]pyrene, diethylnitrosamine, or uracil mustard in female ICR/Ha mice (Wattenberg and Bueding, 1986) . Later, chemopreventive properties of OLT against AFB r induced hepatocarcinogenesis in male F344 rats were demonstrated (Roebuck et al., 1991) . OLT also affords protection against acute and chronic toxic effects. For example, pretreatment of rats or mice with OLT resulted in the inhibition of acute hepatotoxic effects of carbon tetrachloride (Ansher et al., 1983) , acetaminophen (Ansher et al., 1983) , ally] alcohol (Davies et al., 1987) , and AFB, (Liu et al., 1988) . In the rat, OLT appeared to protect against both genotoxic and cytotoxic actions of AFB, when fed before or during AFB, exposure (Kensler et al., 1987; Roebuck et al., 1991; Kensler et al., 1992b) or even as a result of a transient intervention relative to a prolonged AFB, treatment period (Bolton et al., 1993) . Administration of OLT after AFB, exposure occurred, however, yielded no protective effect . To the contrary, in a model of azoxymethane-induced colon carcinogenesis, OLT afforded protection irrespective of time of its administration (Rao et al, 1993) .
Mechanisms of chemoprevention by dithiolethiones are not fully understood. Mechanistic studies indicate that chemoprevention afforded by OLT is due primarily to the enhancement of electrophile detoxication pathways (Kensler et al, 1987; Roebuck et al, 1991) . We have synthesized more than 50 dithiolethione analogs for structure-activity studies aimed at identifying the most effective compounds and molecular structural features among all dithiolethione analogs. These structure-activity studies might help to understand the mechanism by which dithiolethiones inhibit carcinogenesis. For example, De Long et al (1986) reported that 3W-l,2-dithiole-3-thione (D3T) was more effective in the induction of NAD(P)H:quinone reductase in murine Hepa Iclc7 cells in culture than OLT. The examination of the effects of dietary administration of several dithiolethione analogs on inhibition of hepatic AFB,-DNA adduct formation in rats revealed that D3T was the most effective compound in the inhibition of hepatic AFB,-DNA binding and in the induction of electrophile detoxication enzymes, such as glutathione S-transferases (Kensler et al, 1987) .
The present studies were undertaken to characterize further the dithiolethione analogs. Because of the large number of dithiolethiones under investigation and the lack of complete understanding of mechanisms of their biological activity, these studies were undertaken with three specific objectives: (I) to develop an efficient biological screen for more effective dithiolethiones; (2) to define the significance of toxicity in AFB,-induced carcinogenesis; and (3) to examine structure-activity features of dithiolethiones that produce greater biological activity.
MATERIALS AND METHODS
Chemicals. AFB, was obtained from Aldnch Chemical Company (Milwaukee, WI). Pelleted punfied diet was of the AIN-76A formulation (Bieri, 1980) , but without ethoxyquin, and was purchased from Harlan (Madison, WI). OLT was prepared by a modification of the method described by Barreau et al. (1977) . D3T was prepared by the procedure of Meinetsberger et al. (1977) 5-Methyl-3//-l,2-dithiole-3-thione (5mD3T) was prepared from acetone and carbon disulfide by a method to be described elsewhere (Curphey and Libby, unpublished) ADT was the gift of Solevay Pharma (Suresnes, France). 1,3-Dithiole-2-thione (D2T) was obtained from Aldnch Chemical Company Serum alanine aminotransferase (sALT) and serum sorbitol dehydrogenase (sSDH) were measured spectrophotometrically using Sigma diagnostic kits (Sigma Chemical Co., St. Louis, MO). Bromodeoxyuridine (BrdU) was purchased from Sigma. Anti-BrdU monoclonal antibody was supplied by Becton Dickinson (San Jose, CA). lmmunostaining of BrdU-labeled DNA was with the peroxidase-antiperoxidase detection system (Signet Laboratories, Inc., Dedham, MA). The primary glutathione S-transferase Yp antibody for immunohistochemical analysis was purchased from Biotrin International (Dublin, Ireland). The locaJization of the placental form of glutathione S-transferase (GST-P) was done with a peroxidase-antiperoxidase immunoenzymatic staining kit obtained from Dako Corporation (Carpinteria, CA).
Animals.
Male F344 rats were purchased from Charles River Breeding Laboratory (Kingston, NY). Rats were housed in individual, suspended, wire-bottomed cages with free access to deionized water and diet. Fresh diet was fed every other day. Unused diet was stored at 4°C. The animal room was maintained at 22 ± 2°C, 55-65% relative humidity, and had a 12-hr light-dark cycle. Rats were allowed to acclimate to the facilities for 1 week prior to the experiment. They were weighed once a week. Protection against either the acute toxic effects or the carcinogenic effects of AFB, was assessed beginning when the rats were 7 weeks of age. In both experiments, a low or high dose of dithiolethiones (0.1 or 0.3 mmol/kg body wt, respectively) was gavaged three times per week beginning I week prior to AFB, treatment. The dithiolethiones are highly insoluble in aqueous solutions and difficult to keep in suspension. They were gavaged as a powder dispersed in a saturated solution of sucrose. The density and viscosity of the saturated sucrose maintained the dithiolethione particles in suspension. AFB, was dissolved in tricaprylin and was administered by gastric incubation.
Acute toxicity experiment.
A schematic of the experimental protocol is shown in Fig. I . For each of the five dithiolethiones, groups of four rats received either a low or a high dose of a dithiolethione. The five dithiolethiones were D2T, ADT, OLT, 5mD3T, and D3T (see Fig. 2 for chemical structures). Two days following the last treatment with dithiolethiones, rats were challenged with an obviously acutely toxic dose of AFB,. AFB, (50 /ig/100 g body wt) was gavaged for 2 successive days and on the third day the rats were autopsied. The AFB, control group received the AFB, challenge and the no-AFB, control group received the AFB, vehicle, tricaprylin only. Because of the number of assays performed, the groups treated with high and low doses of dithiolethiones were evaluated separately, each with their own AFB, and no-AFB, control groups.
All rats were given two doses of 10 mg BrdU/100 g body wt 5 and 2 hr prior to autopsy and were killed 28 hr after the last dose of AFB,. Blood was collected at autopsy and serum separated, and sALT and sSDH activities were determined within 48 hr. Livers were removed and weighed. Multiple 3-mm sections of hepatic tissue were cut from the right lateral lobe of the liver. These sections were fixed in acetone and embedded in paraffin; one section was stained with hematoxylin and eosin (H&E) and a serial section was stained immunohistochemically for the expression of . Slides were scored blindly as to the identity of the treatment On average, 700 to 900 BDCs were counted in a total of 20 to 30 randomly selected microscopic fields. Based on preliminary observations and to decrease the total number of BDCs that must be counted, two doses of BrdU were used. Labeling index was calculated by dividing the number of labeled nuclei by the total number of nuclei counted.
Tumorigtnesis experiment
A schematic of the experimental protocol is given in Fig. 3 . The same five dithiolethiones were evaluated at the same doses as in the acute toxicity experiment. The schedule of treatment was similar to that described above except that it extended throughout the 2 weeks of AFB, treatment (25 /ig/rat given five times a week for 2 successive weeks) to conform to the previous tumorigenesis experiments ( Kensler et al., 1987 Kensler et al., , 1992a Liu et al., 1988; Maxuitenko et al., 1993) . Both the lowdose and the high-dose (0.1 and 0.3 mmol/kg body wt, respectively) groups were evaluated simultaneously. The AFB, control group received the AFB, challenge and the no-AFB, control group received the AFB, vehicle, tricaprylin only. All groups were composed of eight rats.
All rats were killed 5 weeks after the dithiolethione and AFB, treatments. At autopsy, livers were removed and weighed. Multiple 3-mm sections of hepatic tissue were cut from the right lateral lobe of the liver. These sections were fixed in acetone, embedded in paraffin, stained immunohistochemically for the expression of GST-P by the peroxidase-antiperoxidase com- Expenmental protocol for evaluation of the chemopreventive effects of pretreatment with selected dithiolethiones against AFB,-induced carcinogenesis. Rats were gavaged with 0.1 or 0.3 mmol/kg body wt of D2T, ADT, OLT, 5mD3T, or D3T 3 times a week for 3 weeks starting 1 week prior to the AFB, treatment. Rats received 25 /jg AFB,/rat/day by gavage, five times a week for two successive weeks. Livers were analyzed for GST-P-positive foci 5 weeks after the last dose of AFB,. Arrows indicate single treatments of 25 /xg AFB, /rat; asterisks indicate single doses of dithiolethione plex method (Kaku et at., 1983) , and examined by light microscopy. Focal transectional areas of the GST-P-positive foci and areas of the tissue sections were determined with an image analysis system (Kensler et al., 1987) . The minimal size of a GST-P-positive focus that was counted contained at least five nucleated hepatocytes. Reproducibility of the counts was checked by evaluation of the same sections by two different investigators.
Statistical analysis. Data are expressed as means ± SE. Body weights, liver weights, toxicological indices, and focal data were analyzed by oneway ANOVA followed by Bonferroni multiple comparison tests. The degree of closeness of the linear relationship between two parameters was measured by the correlation coefficient r.
RESULTS

Acute Toxicity Experiment
Using the same tumorigenic protocol as in this report, Liu et al. (1988) determined that maximum AFB r induced hepatic toxicity was sustained within the first two daily doses of AFB,. Therefore, we chose to evaluate toxicity following two doses of AFB,. Proliferation of the hepatobiliary system is a classic observation following exposure to AFB! (Wogan, 1976; Roebuck and Maxuitenko, 1994) . In a preliminary experiment, 25 fig AFB!/100 g body wt for 2 successive days yielded a labeling index on the third day of 8% for the BDCs. Increasing the dose to 50 fig AFB,/100 g body wt for 2 days resulted in a labeling index of 42%. This latter labeling index provided a large dynamic range for an assay dependent on the measurement of the diminution of proliferation. It also should be noted that the change in the BDC labeling index as a result of the AFB, treatment was more pronounced than the change in the activity of serum enzymes. While both sALT and sSDH activities rose only 1.7-fold 24 hr after two doses of 25 fig of AFB,, the change in BDC labeling index was 6.6-fold.
Although low doses of dithiolethiones (0.1 mmol/kg body wt) did not reduce the body weight gain, at the high dose (0.3 mmol/kg body wt) there was some inhibition in normal weight gain, especially in the D2T group (see Table 1 ). Rats fed the low doses of ADT and OLT gained more weight than rats in both control groups. AFB, treatment resulted in body weight losses in all groups receiving low doses of dithiolethiones when compared with no-AFB, control rats. Pretreatment with D3T and 5mD3T partially protected against this effect. With the high doses of dithiolethiones, protection against AFB i-induced body weight loss was increased. At both doses of dithiolethiones, 5mD3T and D3T were more effective than D2T, OLT, and ADT.
AFB, treatment resulted in a statistically significant increase in sSDH and sALT activities when compared with no-AFB, controls (see Fig. 4 ). When low doses of dithiolethiones were tested, only D3T produced a significant reduction in sALT activity. sSDH and sALT activities were significantly reduced by high doses of OLT, 5mD3T, and D3T. The high doses of 5mD3T and D3T offered almost complete protection against AFB,-induced elevation of hepatic enzyme activities in serum.
At autopsy no gross abnormalities of the livers were seen. Under a light microscope, liver architecture and hepatocyte cytology of the no-AFB, control group appeared normal (see Table 1 , histological index). The AFB, treatment led to degeneration and necrosis of the liver in the periportal and into the midzonal region of the lobule. Cellular damage, distortion of hepatic architecture, and hemorrhage, as well 42.6 ± 2.6' 39 1 ± 2.1' 47.7 ± 1.1' 36.2 ± 3.7' 26.1 ± 2.0*' 19.4 ± 1.7*' 0.3 ± 0.1' 44.2 ± 1.7* 44.8 ± 1.1' 44.6 ± 1.1* 34.0 ± 3.5* 14.6 ± 4.1*' 3.2 ± 1.2' 0.5 ±0 1'° Mean ± SE, n = 4. * Mean value for 6 days of pretreatment with dithiolethiones. c Mean value for 2 days of treatment with AFB,. 'Statistically different from no-AFB, control group (p < 0.05) for each dose of dithiolethiones separately. ' Statistically different from AFB, control group (p < 0.05) for each dose of dithiolethiones separately.
as proliferation of portal bile ducts, were observed. Pretreatment of rats with dithiolethiones afforded differing degrees of protection from AFB r induced hepatotoxicity. At the low doses of dithiolethiones, only D3T afforded protection, though, it was not statistically significant. At the high dose of dithiolethiones, however, protection afforded by 5mD3T and D3T was significant (see Table 1 ).
BrdU labeling of the livers of the AFB,-treated rats revealed prominent labeling of the cells in the periductal space and hepatobiliary system, whereas the hepatocytes largely remained unlabeled. The BDC labeling index was increased from less than 1% in the no-AFB i control groups to greater than 40% in the AFB, control groups. This similar response was expected and observed in the two experiments since the same dose of AFB| was used. At both the low and high doses of dithiolethiones, 5mD3T and D3T reduced the labeling index, with the high dose offering a greater reduction (Table 1) .
Tumorigenesis Experiment
As expected, all rats survived the treatment and grew at comparable rates. Body weights at the termination of the experiment did not differ significantly between the groups, nor did the liver weights (data not shown).
The influence of pretreatment with dithiolethiones on the observed number of GST-P-positive foci is shown in Table   2 . GST-P-positive foci are rarely encountered in no-AFB, control rats, whereas the treatment with AFB, resulted in observation of approximately 30 foci when 2 to 3 cm 2 of tissue was examined. Pretreatment with dithiolethiones decreased the observed number of GST-P-positive foci. The high dose was more protective, and ADT, OLT, 5mD3T, and D3T afforded considerable protection. Statistical analysis of the "observed" focal data is subject to sampling biases (Pugh et ai, 1983) since large foci are more likely to be observed than small foci. For this reason statistical approaches cannot be applied directly to the "observed" data. To avoid this bias, morphometric transformation of the data is necessary prior to the analysis (Pugh et ai, 1983) .
The influence of pretreatment with the dithiolethiones on the number of GST-P-positive foci per unit volume of liver and focal size is summarized in Table 2 . The low doses of D3T or 5mD3T reduced the number of GST-P-positive foci per cubic centimeter by more than fivefold and threefold, respectively, while OLT, ADT or D2T had no significant effect. Pretreatment with the high doses of dithiolethiones significantly decreased the number of AFB,-induced GST-P-positive foci per cubic centimeter in all groups. While it seemed that some treatment groups had hepatic GST-Ppositive foci that were distinctly smaller than others, the difference in focal size was not statistically significant.
The influence of pretreatment with the dithiolethiones on the volume percentage of GST-P-positive foci and the extent of inhibition of the focal burden is summarized in Table 3 . It should be noted that the mean focal diameter and the number of foci per cubic centimeter of the liver must be calculated using statistical probabilities (Pugh et ai, 1983) and are less reliable parameters than the volume percentage of the liver occupied by foci. Volume percentage can be directly calculated from the number and transectional areas of foci as seen by light microscopy. The low doses of D3T or 5mD3T resulted in inhibition of GST-P-positive foci, while ADT or OLT did not have a statistically significant inhibitory effect on focal burden. D2T pretreatment had an enhancing effect, yielding a 50% increase in the focal burden. The high doses of D3T, 5mD3T, OLT, and ADT produced even larger reductions in the focal burden than the low doses. The high dose of D2T did not have any effect on the volume percentage of GST-Ppositive foci. A comparison of the volume percentage of GST-P-positive foci in the dithiolethione groups to the volume percentage in the AFB, control group revealed that inhibition of focal burden by greater than 50% was afforded by low doses of ADT, 5mD3T, and D3T and by high doses of all dithiolethiones except D2T.
DISCUSSION
Because of concerns regarding the stability of some dithiolethiones in the diet and limited quantities of many dithio- lethiones synthesized, we chose to gavage the dithiolethiones instead of mixing them in the diet and feeding as we traditionally have done (Kensler et al., 1987 (Kensler et al., , 1992a Liu et al, 1988; Bolton et al, 1993; Maxuitenko et al., 1993) . The additional advantage of gavage is the assurance that all the rats receive equal amounts of the compound. The rats were gavaged with the dithiolethiones three times a week. The doses were designed to approximate the weekly consumption of dithiolethiones from the diet (Kensler et al., 1987 (Kensler et al., , 1992a . That is, gavage with 0.1 mmol OLT or D3T/kg body wt in this experiment is approximately equivalent to 0.01% (100 ppm) or 0.006% (60 ppm) in the diet, respectively. Gavage with 0.3 mmol of OLT or D3T is approximately equivalent to 0.03% (300 ppm) or 0.02% (200 ppm) in the diet, respectively. It should be noted that gavage with dithiolethiones, despite all the advantages mentioned earlier, has one disadvantage: it seems that delivery of dithiolethiones by gavage as a cumulative dose of what the animal would have eaten in the diet over approximately 48 hr results in some toxicity. In the preliminary experiment, we found that a dose of 0.5 mmol D3T/kg body wt (0.03% when given in the diet) was toxic to the rats when given by gavage, but was tolerated when given in the diet (Kensler et al., 1992a) . At 0.5 mmol/ kg body wt, OLT and ADT showed no adverse effects when given by gavage, but 5mD3T and D2T were toxic. Like D3T, no toxicity was seen with repeated doses of these selected dithiolethiones at the 0.3 mmol/kg level. Despite these adverse effects which partly appear to be related to the bolus delivery of the drugs, gavage is advantageous for limited quantities of drugs, uniform dosage, and stability.
Classically, bile duct hyperplasia has been associated with AFBi exposure. BDC proliferation is seen in chickens, ducks, turkeys (Newberne, 1973) , swine (Miller et al., 1981) , dogs (Newberne et al., 1966) , horses (Angsubhakorn et al, 1981) , and rats (Wogan, 1976; Roebuck and Maxuitenko, 1994) exposed to AFB,. We have quantified BDC proliferation resulting from two doses of 50 /j,g of AFB,. As was mentioned earlier, the acute treatment protocol of two doses of 50 /ig of AFB, was chosen to achieve a wider range of toxic responses against which the efficacy of dithiolethiones might be judged. The total dose of AFB, approximates the quantity of AFB, a rat would receive during the first week of a tumorigenic treatment protocol, when most of hepatic toxicity occurs (Liu et al., 1988) . The extent of BDC proliferation significantly (p < 0.01, all 56 rats) correlated with traditional markers of hepatic toxicity, such as sALT (r = 0.835), sSDH (r = 0.829), and extent of hepatic damage (r = 0.902). These findings clearly allow BDC proliferation to be used as an index of AFB,-induced hepatotoxicity. Under conditions of low toxicity, it appears that the BDC labeling index is a more sensitive marker of hepatotoxicity and will be superior to serum markers of toxicity in discriminating among effective compounds. For example, treatment with the high dose of D3T resulted in a 6.4-fold increase in the BDC labeling index; whereas, sALT and sSDH activities were increased only 3-and 1.4-fold, respectively when compared with the no-AFB, control group.
Previous studies demonstrated that ingestion of OLT or D3T during AFB, treatment diminished hepatotoxicity (Liu et al., 1988) , retarded the development of putative preneoplastic lesions (Kensler et al, 1987 (Kensler et al, , 1992a Bolton et al, 1993; Maxuitenko et al, 1993) , and ultimately prevented cancer (Roebuck et al., 1991) . However, neither the relationship between hepatotoxicity and hepatocarcinogenicity associated with AFBj exposure nor the mechanisms responsible for BDC hyperplasia by AFB, are understood. It was proposed (Liu et al., 1988; Kensler et al., 1992c) that OLT may act indirectly through the activation of electrophile detoxication enzymes to decrease the hepatotoxicity of AFB, and thereby reduce parenchyma! cell proliferation, thus conferring cancer chemoprevention. To explore any relationship between hepatotoxicity and tumorigenicity of AFB,, all toxicological indices were correlated to the volume percentage of the liver occupied by GST-P-positive foci. These correlations were statistically significant (p < 0.01) for all toxicological indices used (Fig. 5 ). While correlation is certainly not causation, the degree of association is impressive and consistent. These results imply that inhibition of AFB r induced hepatotoxicity affords protection against putative preneoplastic focal development. The explanation could be that cell death resulting from AFBj exposure causes loss of liver cell mass which in turn results in compensatory cell proliferation. Hepatotumorigenicity studies have demonstrated that proliferating cells are more susceptible to carcinogens (Solt and Farber, 1976) , and cell proliferation has been recognized as an important factor in cancer development (Cohen and Ellwein, 1990) . It is likely to play an important role in fixation of carcinogen-induced DNA damage and in the clonal expansion of initiated cells. The important role of cell regeneration induced by hepatotoxins requires further investigation to understand the mechanisms that control cell division in postnecrotic liver regeneration.
Of the more than 50 dithiolethione analogs we have synthesized and the many others that are already available, 5 were chosen to span a wide range of chemopreventive responses for the development of this approach. Based on the activities of these 5 compounds, it seems clear that the presence of the 3//-l,2-dithiole-3-thione structure is necessary for the compound to exhibit protective properties. Thus, the analog lacking this moiety, D2T, was devoid of chemopreventive activity. The requirement of the 3W-l,2-dithiole-3-thione nucleus for activity, as well as the relative ranking among the compounds in our study, agrees reasonably well with previous observations of chemoprevention by these agents in vivo. Thus, Bueding and co-workers found that OLT and ADT afforded similar protection against hepatotoxicity induced by carbon tetrachloride or acetaminophen in female CD-I mice, as measured by survival and by effect on serum enzyme, glutathione, and glutathione S-transferase levels (Ansher et al, 1983) . In a more extensive study which examined phase 2 enzyme induction in various tissues of mice and rats, these workers again found OLT and ADT to have similar activities, although OLT appeared somewhat more active than ADT (Ansher et al., 1986) . In our own study of the effects of 8 dithiolethione analogs on AFB, metabolism and DNA adduct formation in male F344 rats, we found D3T to be considerably more effective at induction of phase 2 enzymes and suppression of AFB,-DNA adduct formation than either OLT or ADT, with OLT being somewhat more effective than ADT (Kensler et al., 1987) . Structure-activity information is also available from two in vitro studies employing the Hepa Iclc7 murine hepatoma cell line. The Bueding group found the parent D3T to be more effective than either OLT or ADT at induction of NAD(P)H:quinone reductase in this cell line, with OLT and ADT displaying similar, although somewhat dose-dependent, activity (De Long et al., 1986) . Under some conditions, however, OLT was found to be more effective at elevating cellular glutathione levels than was D3T. In a study that measured the ability of 25 dithiolethiones and analogs to induce NAD(P)H:quinone reductase in Hepa Iclc7 cells transfected with the p41-285GH plasmid, D3T was found to be a more potent inducer than OLT, ADT, or 5mD3T, whose inducing potencies were very similar (Egner et al., 1994) . In agreement with the current study, D2T was found to be devoid of inducing activity. Given the many different measures of chemoprevention that have been employed, the correspondence between previous structure-activity studies and the present study is quite good, suggesting that the methods presented here constitute a valid approach to screening the many available dithiolethiones for cancer chemopreventive activity.
To date, we have identified 10 to 20 dithiolethiones that have greater enzyme induction properties in vitro and in vivo than does OLT (Kensler and Curphey, unpublished data) . It is anticipated that many of them will be found to be more effective than OLT, which is an extremely effective cancer chemopreventive agent (Roebuck et al., 1991; Bolton et al., 1993) .
